Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Shiri Davidi"'
Autor:
Roni Blatt, Shiri Davidi, Mijal Munster, Anna Shteingauz, Shay Cahal, Adel Zeidan, Tal Marciano, Zeev Bomzon, Adi Haber, Moshe Giladi, Uri Weinberg, Adrian Kinzel, Yoram Palti
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundTumor Treating Fields (TTFields) therapy is a non-invasive, loco-regional, anti-mitotic treatment modality that targets rapidly dividing cancerous cells, utilizing low intensity, alternating electric fields at cancer-cell-type specific freq
Externí odkaz:
https://doaj.org/article/01d62b8fe64b4ea2ba3b073c3fa8e672
Autor:
Shiri Davidi, Roni Blat, Mijal Munster, Anna Shteingauz, Shay Cahal, Moshe Giladi, Uri Weinberg, Yoram Palti
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/e7cd3a1817c340d2808a0c944ae9a8da
Autor:
Michal Munster, Ella Fremder, Valeria Miller, Neta Ben-Tsedek, Shiri Davidi, Stefan J Scherer, Yuval Shaked
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e95983 (2014)
Tumor derived microparticles (TMPs) have recently been shown to contribute to tumor re-growth partially by inducing the mobilization and tumor homing of specific bone marrow derived pro-angiogenic cells (BMDCs). Since antiangiogenic drugs block proan
Externí odkaz:
https://doaj.org/article/9aa513b95afd4f50832587cc0151743d
Autor:
Tali Voloshin, Mijal Munster, Yuval Shmueli, Uri Weinberg, Adi Haber, Anna Shteingauz, Helena Mumblat, Shiri Davidi, Shiri Danilov, Moshe Giladi, Einav Zeevi, Yoram Palti, Antonia Martinez-Conde, Adrian Kinzel, Catherine Tempel-Brami, Yaara Porat, Eyal Dor-On, Ori Braten, Carolina Lajterer, Rosa S. Schneiderman, Roni Blatt
Publikováno v:
Lung Cancer. 160:99-110
Objectives Tumor Treating Fields (TTFields) are low intensity, intermediate frequency, alternating electric fields with antimitotic effects on cancerous cells. TTFields concomitant with pemetrexed and a platinum agent are approved in the US and EU as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4f4ed745c65ea1f000e412d10635e98
https://doi.org/10.1016/j.lungcan.2021.08.011
https://doi.org/10.1016/j.lungcan.2021.08.011
Autor:
Naama Flint-Brodsly, Einav Zeevi, Kerem Wainer-Katsir, Hila Fishman, Antonia Martinez-Conde, Eyal Dor-On, Mijal Munster, Yaara Porat, Tali Voloshin, Shiri Davidi, Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti
Publikováno v:
Cancer Research. 83:2723-2723
Background: Gastric cancer, one of the most common types of cancers, is mainly treated with the FOLFOX chemotherapy regimen (oxaliplatin, fluorouracil [5-FU], and leucovorin); yet long-term survival remains poor. Tumor Treating Fields (TTFields) are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::907be962c4794c68ccb1d4d8e41e9b24
https://doi.org/10.1158/1538-7445.am2023-2723
https://doi.org/10.1158/1538-7445.am2023-2723
Autor:
Shay Cahal, Yaara Porat, Moshe Giladi, Eilon D. Kirson, A. Shteingauz, Adrian Kinzel, Aviran Itzhaki, Einav Zeevi, Uri Weinberg, Tali Voloshin, Yoram Palti, Catherine Tempel Brami, Mijal Munster, Noa Kaynan, Shiri Davidi, Rosa S. Schneiderman, Roni Blat
Publikováno v:
Cancer Immunology, Immunotherapy
Tumor-treating fields (TTFields) are alternating electric fields in a specific frequency range (100–300 kHz) delivered to the human body through transducer arrays. In this study, we evaluated whether TTFields-mediated cell death can elicit antitumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9715fe0f2ba8490d0c2aedea5d2f136b
https://doi.org/10.1007/s00262-020-02534-7
https://doi.org/10.1007/s00262-020-02534-7
Autor:
Shiri, Davidi, Sara, Jacobovitch, Anna, Shteingauz, Antonia, Martinez-Conde, Ori, Braten, Catherine, Tempel-Brami, Einav, Zeevi, Roni, Frechtel-Gerzi, Hila, Ene, Eyal, Dor-On, Tali, Voloshin, Itai, Tzchori, Adi, Haber, Moshe, Giladi, Adrian, Kinzel, Uri, Weinberg, Yoram, Palti
Publikováno v:
Cancers. 14(12)
Hepatocellular carcinoma (HCC), a highly aggressive liver cancer, is a leading cause of cancer-related death. Tumor Treating Fields (TTFields) are electric fields that exert antimitotic effects on cancerous cells. The aims of the current research wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d1063f80ee7db0da289ded88759dd9d5
https://pubmed.ncbi.nlm.nih.gov/35740624
https://pubmed.ncbi.nlm.nih.gov/35740624
Autor:
Shiri Davidi, Sara Jacobovitch, Anna Shteingauz, Antonia Martinez-Conde, Ori Braten, Catherine Tempel-Brami, Einav Zeevi, Roni Frechtel-Gerzi, Hila Ene, Eyal Dor-On, Tali Voloshin, Itai Tzchori, Adi Haber, Moshe Giladi, Adrian Kinzel, Uri Weinberg, Yoram Palti
Publikováno v:
Cancers. 15:1182
The authors wish to make minor corrections to Figure 1 and Figure 2 of the following paper [...]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b03a11d50bbc77c6f02e6e2ffa93496
https://doi.org/10.3390/cancers15041182
https://doi.org/10.3390/cancers15041182
Autor:
Adi Haber, Roni Blatt, Anna Shteingauz, Zeev Bomzon, Shiri Davidi, Shay Cahal, Adrian Kinzel, Uri Weinberg, Adel Zeidan, Moshe Giladi, Mijal Munster, Yoram Palti, Tal Marciano
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundTumor Treating Fields (TTFields) therapy is a non-invasive, loco-regional, anti-mitotic treatment modality that targets rapidly dividing cancerous cells, utilizing low intensity, alternating electric fields at cancer-cell-type specific freq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9105e57568800a24f073a9a1c92383c
https://www.frontiersin.org/articles/10.3389/fonc.2021.670809/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.670809/full
Autor:
Kerem Wainer-Katsir, Gitit Lavy-Shahaf, Shiri Davidi, Sara Jacobovitch, Tali Voloshin, Itai Tzchori, Yaara Porat, Lianghao Ding, Michael Story, Niv Pencovich, Ilan Volovitz, Joshua Branter, Stuart J. Smith, Adi Haber, Moshe Giladi, Uri Weinberg, Yoram Palti
Publikováno v:
Cancer Research. 82:1866-1866
Introduction: Tumor Treating Fields (TTFields) are alternating electric fields that disrupt the function of polarized molecules within cancer cells. Initial data showed an anti-mitotic effect on cancerous cells whilst more recent findings confirmed a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::54be61e9f9be4455fbc7455365229f6d
https://doi.org/10.1158/1538-7445.am2022-1866
https://doi.org/10.1158/1538-7445.am2022-1866